U.S. Home Infusion Therapy Market Size, Growth and Trends 2025

Market Trends

Rise in Chronic Disease Management at Home ● Increasing use of home infusion therapy for cancer, diabetes, and infections. ● Enhances patient comfort, reduces hospital visits.

Technological Advancements ● Smart infusion pumps, remote monitoring, and portable devices improve care and safety. ● Innovation in elastomeric pumps boosts adoption for OPAT and chemotherapy.

Strategic Collaborations and Expansions ● GC Biopharma partnered with AOM Infusion for ALYGLO distribution (Nov 2024). ● Shields Health Solutions expanded specialty pharmacy with UnityPoint (July 2024).

Regulatory Approvals ● Eisai and Biogen’s subcutaneous Alzheimer’s therapy LEQEMBI approved in Jan 2025. ● Duke Home Infusion Pharmacy opened in April 2025 to support local care expansion.

Market Insights

● Infusion Pumps Dominated: 43% market share in 2023. ● Cancer & Diabetes: Responsible for 36% of the market demand in 2023. ● Anti-infective Applications: Held the largest market share by application in 2024. ● Endocrinology: Fastest-growing application segment due to diabetes surge. ● 3.2 million Americans currently receive home infusion therapy annually (NHIA).

Market Dynamics

Drivers

Increasing Cancer & Diabetes Cases Chronic illnesses need long-term treatment that home infusion supports.

Aging U.S. Population More seniors require home-based treatment solutions.

Cost Reduction for Patients and Facilities Reduces inpatient stay, hospital-acquired infections, and insurance expenses.

Technological Innovation Portable pumps, smart devices, and remote care increase adoption.

Challenges

Healthcare Policies and Reimbursement Gaps Current U.S. regulations still favor hospital-based treatments.

Knowledge Gap Between Clinicians & Home Care Providers Can lead to inconsistent outcomes if not bridged.

Regional Segments

United States (Developed Region Focus)

● High adoption due to:

● Aging population

● Advanced home healthcare infrastructure

● Shift toward patient-centric care

● ~3.2 million patients currently use home infusion services (NHIA, 2024)

Western Europe (Comparative Growth)

● Similar trends observed due to public healthcare models favoring home care.

Segment Highlights

By Product

Infusion Pumps (Largest Share, 2024) ● Includes ambulatory, volumetric, PCA, syringe, and elastomeric pumps. ● Smart pump tech improves dosage safety and user alerts.

Needleless Connectors (Fastest Growing) ● Reduces infection risks and provides safer IV access.

By Application

Anti-Infective (Largest Share, 2024) ● Used for pneumonia, sepsis, herpes, etc. ● Enables severe infection treatment at home.

Endocrinology (Fastest Growing Segment) ●Driven by rising diabetes rates (589 million globally in 2024, IDF). ●Includes insulin, testosterone, and hormone infusion therapy.

Top Companies 2025